• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Delivery of chemotherapeutics using spheres made of bioengineered spider silks derived from MaSp1 and MaSp2 proteins.使用由 MaSp1 和 MaSp2 蛋白衍生的生物工程蛛丝制成的球体来输送化疗药物。
Nanomedicine (Lond). 2018 Feb;13(4):439-454. doi: 10.2217/nnm-2017-0276. Epub 2018 Jan 17.
2
Bioengineering the spider silk sequence to modify its affinity for drugs.对蜘蛛丝序列进行生物工程改造,以改变其对药物的亲和力。
Int J Nanomedicine. 2018 Jul 20;13:4247-4261. doi: 10.2147/IJN.S168081. eCollection 2018.
3
Blending two bioengineered spider silks to develop cancer targeting spheres.将两种生物工程蜘蛛丝混合以开发癌症靶向球体。
J Mater Chem B. 2017 Apr 28;5(16):3000-3011. doi: 10.1039/c7tb00233e. Epub 2017 Apr 5.
4
Functionalized spider silk spheres as drug carriers for targeted cancer therapy.功能化蜘蛛丝球体作为靶向癌症治疗的药物载体
Biomacromolecules. 2014 Aug 11;15(8):2971-81. doi: 10.1021/bm500591p. Epub 2014 Jul 7.
5
The method of purifying bioengineered spider silk determines the silk sphere properties.生物工程蜘蛛丝的提纯方法决定了丝球的性质。
Sci Rep. 2016 Jun 17;6:28106. doi: 10.1038/srep28106.
6
In vivo study of the immune response to bioengineered spider silk spheres.体内研究对生物工程蜘蛛丝球的免疫反应。
Sci Rep. 2022 Aug 5;12(1):13480. doi: 10.1038/s41598-022-17637-7.
7
Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications.用于治疗应用的生物工程蜘蛛丝和氧化铁纳米粒子的复合球体。
PLoS One. 2019 Jul 15;14(7):e0219790. doi: 10.1371/journal.pone.0219790. eCollection 2019.
8
Reproducing natural spider silks' copolymer behavior in synthetic silk mimics.在合成丝模拟物中再现天然蜘蛛丝的共聚物行为。
Biomacromolecules. 2012 Dec 10;13(12):3938-48. doi: 10.1021/bm301110s. Epub 2012 Nov 8.
9
Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres.靶向 Her2 的丝纳米球的细胞摄取、细胞内分布和降解。
Int J Nanomedicine. 2019 Aug 26;14:6855-6865. doi: 10.2147/IJN.S217854. eCollection 2019.
10
MMPs-responsive silk spheres for controlled drug release within tumor microenvironment.用于在肿瘤微环境中控制药物释放的基质金属蛋白酶响应性丝球
Int J Biol Macromol. 2024 Jun;269(Pt 1):132016. doi: 10.1016/j.ijbiomac.2024.132016. Epub 2024 Apr 30.

引用本文的文献

1
Developing the Strategy to Use Silk Spheres for Efficient, Targeted Delivery of Oligonucleotide Therapeutics to Cancer Cells.制定使用丝球体将寡核苷酸治疗剂高效、靶向递送至癌细胞的策略。
Int J Nanomedicine. 2025 Jun 23;20:8023-8039. doi: 10.2147/IJN.S519906. eCollection 2025.
2
Delivery of Polypeptide Drugs Using Nanoparticles Made of Recombinant Spider Silks Derived From MaSp4 Protein.使用源自MaSp4蛋白的重组蜘蛛丝制成的纳米颗粒递送多肽药物。
Int J Nanomedicine. 2025 Mar 3;20:2609-2622. doi: 10.2147/IJN.S510273. eCollection 2025.
3
Spider minor ampullate silk protein nanoparticles: an effective protein delivery system capable of enhancing systemic immune responses.微小壶腹蛛丝蛋白纳米颗粒:一种能够增强全身免疫反应的有效蛋白质递送系统。
MedComm (2020). 2024 Jun 15;5(7):e573. doi: 10.1002/mco2.573. eCollection 2024 Jul.
4
Review of Spider Silk Applications in Biomedical and Tissue Engineering.蜘蛛丝在生物医学和组织工程中的应用综述
Biomimetics (Basel). 2024 Mar 11;9(3):169. doi: 10.3390/biomimetics9030169.
5
Factors Influencing Properties of Spider Silk Coatings and Their Interactions within a Biological Environment.影响蜘蛛丝涂层性能及其在生物环境中相互作用的因素。
J Funct Biomater. 2023 Aug 19;14(8):434. doi: 10.3390/jfb14080434.
6
Self-Assembly of RGD-Functionalized Recombinant Spider Silk Protein into Microspheres in Physiological Buffer and in the Presence of Hyaluronic Acid.在生理缓冲液中和存在透明质酸的情况下,RGD 功能化重组蜘蛛丝蛋白自组装成微球。
ACS Appl Bio Mater. 2023 Sep 18;6(9):3696-3705. doi: 10.1021/acsabm.3c00373. Epub 2023 Aug 14.
7
Delivering on the promise of recombinant silk-inspired proteins for drug delivery.兑现基于丝蛋白的重组蛋白类药物传递系统的承诺。
Adv Drug Deliv Rev. 2023 Jan;192:114622. doi: 10.1016/j.addr.2022.114622. Epub 2022 Nov 19.
8
In vivo study of the immune response to bioengineered spider silk spheres.体内研究对生物工程蜘蛛丝球的免疫反应。
Sci Rep. 2022 Aug 5;12(1):13480. doi: 10.1038/s41598-022-17637-7.
9
Bioactive Keratin and Fibroin Nanoparticles: An Overview of Their Preparation Strategies.生物活性角蛋白和丝素蛋白纳米颗粒:其制备策略概述
Nanomaterials (Basel). 2022 Apr 20;12(9):1406. doi: 10.3390/nano12091406.
10
Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy.用于癌症治疗的基于丝的全身和局部给药系统。
Cancers (Basel). 2021 Oct 27;13(21):5389. doi: 10.3390/cancers13215389.

本文引用的文献

1
Micromechanical characterization of spider silk particles.蜘蛛丝颗粒的微观力学特性
Biomater Sci. 2013 Nov 1;1(11):1160-1165. doi: 10.1039/c3bm60108k. Epub 2013 Jul 25.
2
Blending two bioengineered spider silks to develop cancer targeting spheres.将两种生物工程蜘蛛丝混合以开发癌症靶向球体。
J Mater Chem B. 2017 Apr 28;5(16):3000-3011. doi: 10.1039/c7tb00233e. Epub 2017 Apr 5.
3
Biomineralization of Engineered Spider Silk Protein-Based Composite Materials for Bone Tissue Engineering.用于骨组织工程的工程化蜘蛛丝蛋白基复合材料的生物矿化
Materials (Basel). 2016 Jul 11;9(7):560. doi: 10.3390/ma9070560.
4
Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.功能化生物工程蜘蛛丝球体提高核酸酶抗性和寡核苷酸疗法的活性,为癌症治疗提供了一种策略。
Acta Biomater. 2017 Sep 1;59:221-233. doi: 10.1016/j.actbio.2017.07.014. Epub 2017 Jul 8.
5
Cellular uptake of drug loaded spider silk particles.载药蜘蛛丝颗粒的细胞摄取。
Biomater Sci. 2016 Sep 20;4(10):1515-1523. doi: 10.1039/c6bm00435k.
6
Surface-Functionalized Silk Fibroin Films as a Platform To Guide Neuron-like Differentiation of Human Mesenchymal Stem Cells.表面功能化丝素蛋白薄膜作为一种平台,可指导人骨髓间充质干细胞向神经元样细胞分化。
ACS Appl Mater Interfaces. 2016 Sep 7;8(35):22849-59. doi: 10.1021/acsami.6b06403. Epub 2016 Aug 23.
7
The method of purifying bioengineered spider silk determines the silk sphere properties.生物工程蜘蛛丝的提纯方法决定了丝球的性质。
Sci Rep. 2016 Jun 17;6:28106. doi: 10.1038/srep28106.
8
Pigmented Silk Nanofibrous Composite for Skeletal Muscle Tissue Engineering.用于骨骼肌组织工程的色素化丝纳米纤维复合材料。
Adv Healthc Mater. 2016 May;5(10):1222-32. doi: 10.1002/adhm.201501066. Epub 2016 Mar 22.
9
Silk as an innovative biomaterial for cancer therapy.丝绸作为一种用于癌症治疗的创新生物材料。
Rep Pract Oncol Radiother. 2014 Dec 18;20(2):87-98. doi: 10.1016/j.rpor.2014.11.010. eCollection 2015 Mar-Apr.
10
Biomimetic fibers made of recombinant spidroins with the same toughness as natural spider silk.具有与天然蜘蛛丝一样韧性的重组蜘蛛丝仿生纤维。
Adv Mater. 2015 Apr 1;27(13):2189-94. doi: 10.1002/adma.201404234. Epub 2015 Feb 16.

使用由 MaSp1 和 MaSp2 蛋白衍生的生物工程蛛丝制成的球体来输送化疗药物。

Delivery of chemotherapeutics using spheres made of bioengineered spider silks derived from MaSp1 and MaSp2 proteins.

机构信息

Chair of Medical Biotechnology, Poznan University of Medical Sciences, 61-688 Poznan, Poland.

NanoBioMedical Centre, Adam Mickiewicz University, 61-614 Poznan, Poland.

出版信息

Nanomedicine (Lond). 2018 Feb;13(4):439-454. doi: 10.2217/nnm-2017-0276. Epub 2018 Jan 17.

DOI:10.2217/nnm-2017-0276
PMID:29338625
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5810845/
Abstract

AIM

Analysis of the properties and chemotherapeutics delivery potential of spheres made of bioengineered spider silks MS1 and MS2.

MATERIALS & METHODS: MS1 and MS2 derived from Nephila clavipes dragline silks - MaSp1 and MaSp2, respectively - formed spheres that were compared in terms of physicochemical properties, cytotoxicity and loading/release of chemotherapeutics.

RESULTS

MS2 spheres were more dispersed, smaller, of solid core, of higher beta-sheet structure content, and of opposite (negative) charge than MS1 spheres. Preloaded MS2 showed greater applicability for mitoxantrone, while postloaded for etoposide delivery compared with MS1 spheres. However, MS1 spheres were a better choice for doxorubicin delivery than MS2.

CONCLUSION

Bioengineered silks can be tailored to develop a system with optimal drug loading and release properties.

摘要

目的

分析由生物工程蛛丝 MS1 和 MS2 制成的球体的特性和化疗药物传递潜力。

材料与方法

MS1 和 MS2 分别来自金蛛牵引丝 MaSp1 和 MaSp2,形成了球体,从理化性质、细胞毒性以及化疗药物的负载/释放方面对它们进行了比较。

结果

MS2 球体更分散、更小、为实心核、β-折叠结构含量更高、带相反(负)电荷,而 MS1 球体则相反。与 MS1 球体相比,载有米托蒽醌的 MS2 球体具有更高的适用性,而载有依托泊苷的 MS1 球体则具有更高的适用性。然而,MS1 球体在阿霉素传递方面优于 MS2 球体。

结论

生物工程丝可以进行定制,以开发出具有最佳药物负载和释放特性的系统。